-
IAXO-102
- names:
IAXO-102
- CAS号:
1115270-63-7
MDL Number: - MF(分子式): C35H71NO5 MW(分子量): 585.94
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM004657-10mg | 10mg | >98.0% | ¥ 7425.00 | ¥ 7425.00 | 2-3天 | ¥ 0.00 | ||
| YZM004657-5mg | 5mg | >98.0% | ¥ 4550.00 | ¥ 4550.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | IAXO-102 |
| CAS号 | 1115270-63-7 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C35H71NO5 |
| 分子量 Molecular Weight | 585.94 |
| 溶解度Solubility | 生物体外In Vitro:Ethanol : 50 mg/mL(85.33 mM;Need ultrasonic)DMSO溶解度< 1 mg/mL(insoluble or slightly soluble) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | IAXO02 is aTLR4antagonist which negatively regulates TLR4 signalling. It inhibits MAPK and p65 NFB phosphorylation and expression of TLR4 dependent proinflammatory protein. IAXO02 also prevents experimental abdominal aortic aneurysm development. |
| Application1 | |
| Application2 | |
| Application3 |
IAXO-102 为TLR4的拮抗剂,抑制 TLR4 信号通路。IAXO-102 抑制 MAPK 和 p65 NF-kB 的磷酸化及 TLR4 和 TLR4 依赖性的炎性蛋白的表达。IAXO-102 抑制实验性腹主动脉瘤的发展。IAXO-102 is aTLR4antagonist which negatively regulates TLR4 signalling. It inhibits MAPK and p65 NF-κB phosphorylation and expression of TLR4 dependent proinflammatory protein. IAXO-102 also prevents experimental abdominal aortic aneurysm development[1].
【1】.Huggins C, et al. A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development. Atherosclerosis. 2015 Oct;242(2):563-70.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


